Dupilumab Improves Disease-Specific Quality of Life in Patients With Prurigo Nodularis (LIBERTY-PN PRIME and PRIME2)

被引：0
|
作者：
Kwatra, Shawn [1 ]
Yosipovitch, Gil [2 ]
Mollanazar, Nicolas [3 ]
Stander, Sonja [4 ]
Kim, Brian S. [5 ]
Msihid, Jerome [6 ]
Bansal, Ashish [7 ]
O'Malley, John T. [8 ]
Bahloul, Donia [6 ]
Thomas, Ryan B. [7 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Miami, Miami, FL USA
[3] Univ Penn, Philadelphia, PA USA
[4] Univ Hosp Munster, Munster, Germany
[5] Icahn Sch Med Mt Sinai, New York, NY USA
[6] Sanofi, Chilly Mazarin, France
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Cambridge, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42014
引用
收藏
页码：AB39 / AB39
页数：1
相关论文
共 50 条
  • [1] Dupilumab Improves Multiple Factors Impacting Quality of Life in Adults With Prurigo Nodularis (LIBERTY-PN PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Mollanazar, Nicholas
    Staender, Sonja
    Kim, Brian S.
    Msihid, Jerome
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB150 - AB150
  • [2] Dupilumab improves patient-reported itch and other signs and symptoms of disease in adults with prurigo nodularis (LIBERTY-PN PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Guillemin, Isabelle
    Msihid, Jerome
    Wiggins, Simmi
    Levit, Noah A.
    McDonald, Robert
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [3] Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Mendes-Bastos, Pedro
    Tsai, Tsen-Fang
    Kim, Brian S.
    Praestgaard, Amy
    Bansal, Ashish
    Makhija, Melanie
    Bahloul, Donia
    Thomas, Ryan B.
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II15 - II17
  • [4] Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Yosipovitch, Gil
    Kim, Brian S.
    Kwatra, Shawn G.
    Mollanazar, Nicholas K.
    Stander, Sonja
    Satoh, Takahiro
    Mendes-Bastos, Pedro
    Tsai, Tsen-Fang
    Laws, Elizabeth
    Nivens, Michael C.
    Maloney, Jennifer
    Shi, Genming
    Bansal, Ashish
    Dubost-Brama, Ariane
    JAAD INTERNATIONAL, 2024, 16 : 163 - 174
  • [5] Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients With Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Guillemin, Isabelle
    Msihid, Jerome
    Wiggins, Simmi
    Levit, Noah A.
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [6] Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Mollanazar, Nicholas
    Staender, Sonja
    Satoh, Takahiro
    Laws, Elizabeth
    Mannent, Leda P.
    Mortensen, Eric
    Maloney, Jennifer
    Shi, Genming
    Bansal, Ashish
    Martincova, Renata
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [7] Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (liberty-pn prime and prime2)
    Yosipovitch, G.
    Kwatra, S. G.
    Mollanazar, N.
    Staender, S.
    Satoh, T.
    Laws, E.
    Mannent, L. P.
    Mortensen, E.
    Maloney, J.
    Shi, G.
    Bansal, A.
    Martincova, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S111 - S111
  • [8] Dupilumab Improves Itch, Skin Pain, and Sleep in Adult PatientsWith Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Guillemin, Isabelle
    Msihid, Jerome
    Wiggins, Simmi
    Levit, Noah A.
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 100
  • [9] Dupilumab is efficacious in patients with prurigo nodularis regardless of baseline lesion severity: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Staender, Sonja
    Misery, Laurent
    Yosipovitch, Gil
    Park, Chang Ook
    Li, Lin-Feng
    Praestgaard, Amy
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 18 - 19
  • [10] Dupilumab is efficacious in patients with prurigo nodularis regardless of history of atopic comorbidities: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Kim, Brian S.
    Goncalo, Margarida
    Ugajin, Tsukasa
    Praestgaard, Amy
    Makhija, Melanie
    Zahn, Joseph
    Bansal, Ashish
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II11 - II12
12345